I just got this notice from the FDA. Very interesting development.
https://s3.amazonaws.com/public-inspection.federalregister.gov/2016-27456.pdf
https://s3.amazonaws.com/public-inspection.federalregister.gov/2016-27456.pdf
I've been digging a little deeper on this. It looks like this is a withdrawal of the FDA's methodology on denying premarket applications. It looks like they've determined they made the door too narrow regarding new products coming to market and are reconsidering the process of accepting apps.But I can't be certain of what exactly it is withdrawing.